Current and emerging therapies for Achondroplasia: The dawn of precision medicine

[Display omitted] Achondroplasia is a rare disease affecting bone growth and is caused by a missense mutation in the fibroblast growth factor receptor 3 (FGFR3) gene. In the past few years, there were multiple experimental drugs entering into clinical trials for treating achondroplasia including vos...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Bioorganic & medicinal chemistry 2023-05, Vol.87, p.117275-117275, Article 117275
Hauptverfasser:	Dardenne, Etienne, Ishiyama, Noboru, Lin, Tai-An, Lucas, Matthew C
Format:	Artikel
Sprache:	eng
Schlagworte:	Achondroplasia Achondroplasia - drug therapy Achondroplasia - genetics FGFR3 mutations Fibroblast growth factor 3 Humans Mutation Precision Medicine Quality of Life Skeletal dysplasia
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!